Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Brain & Development
- Vol. 9 (3) , 270-282
- https://doi.org/10.1016/s0387-7604(87)80044-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitisThe Journal of Pediatrics, 1982
- INOSIPLEX THERAPY IN SUBACUTE SCLEROSING PANENCEPHALITISThe Lancet, 1982
- Effects of Inosiplex on Viral Growth and Experimental Viral InfectionsKansenshogaku Zasshi, 1981
- Effects of Inosiplex on Host Defense Against InfectionsKansenshogaku Zasshi, 1981
- Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled studyAnnals of Neurology, 1980
- Unusual features in a Case Diagnosed as Subacute Sclerosing Panencephalitis (SSPE)Zeitschrift für Neurologie, 1979
- Isoprinosine in subacute sclerosing panencephalitisNeurology, 1979
- Inosiplex in the Treatment of Subacute Sclerosing PanencephalitisArchives of Neurology, 1979
- The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)Annals of Neurology, 1977
- Immunopathologic observations in subacute sclerosing panencephalitisNeurology, 1968